Similarly, ASCT2 expression was found to be upregulated in several cancers, including colorectal cancer [14], breast cancer [15], non-small cell lung cancer [22], and clear-cell renal cell carcinoma [23]. Here, SLC1A5 is linked to non-small cell lung carcinoma.